000 01550 a2200421 4500
005 20250517204336.0
264 0 _c20180816
008 201808s 0 0 eng d
022 _a1746-6148
024 7 _a10.1186/s12917-018-1411-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZambrano-Estrada, Xóchitl
245 0 0 _aMolecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.
_h[electronic resource]
260 _bBMC veterinary research
_cMar 2018
300 _a87 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aDog Diseases
_xdrug therapy
650 0 4 _aDogs
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aIodine
_xadministration & dosage
650 0 4 _aMammary Neoplasms, Animal
_xdrug therapy
650 0 4 _aNeoadjuvant Therapy
_xmethods
700 1 _aLandaverde-Quiroz, Brianda
700 1 _aDueñas-Bocanegra, Andrés A
700 1 _aDe Paz-Campos, Marco A
700 1 _aHernández-Alberto, Gerardo
700 1 _aSolorio-Perusquia, Benjamín
700 1 _aTrejo-Mandujano, Manuel
700 1 _aPérez-Guerrero, Laura
700 1 _aDelgado-González, Evangelina
700 1 _aAnguiano, Brenda
700 1 _aAceves, Carmen
773 0 _tBMC veterinary research
_gvol. 14
_gno. 1
_gp. 87
856 4 0 _uhttps://doi.org/10.1186/s12917-018-1411-6
_zAvailable from publisher's website
999 _c28170120
_d28170120